Eric Poma
Chief Executive Officer bij MOLECULAR TEMPLATES, INC.
Vermogen: 41 456 $ op 31-03-2024
Profiel
Eric E.
Poma is the founder of Molecular Templates, Inc. (founded in 2000) where he holds the title of Director, Chief Executive & Scientific Officer.
He is currently the Chief Executive Officer & Director at Molecular Templates OpCo, Inc. Dr. Poma's former positions include Vice President-Business Development at ImClone LLC (2001-2013) and Secretary & Vice President-Business Development at Innovive Pharmaceuticals, Inc. (2009-2013).
Dr. Poma's education history includes an undergraduate and doctorate degree from The University of North Carolina at Charlotte and an MBA from The Leonard N Stern School of Business.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
23-01-2024 | 18 507 ( 0.34% ) | 41 456 $ | 31-03-2024 |
Actieve functies van Eric Poma
Bedrijven | Functie | Begin |
---|---|---|
MOLECULAR TEMPLATES, INC. | Chief Executive Officer | 01-01-2000 |
Molecular Templates OpCo, Inc.
Molecular Templates OpCo, Inc. Financial ConglomeratesFinance Molecular Templates OpCo, Inc. provides medical services. The company is headquartered in Austin, TX. | Chief Executive Officer | - |
Eerdere bekende functies van Eric Poma
Bedrijven | Functie | Einde |
---|---|---|
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Corporate Officer/Principal | - |
Innovive Pharmaceuticals, Inc.
Innovive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology The Group's principal activity is developing compounds for the treatment of cancer. It currently have four products in development; INNO-406, tamibarotene, INNO-206 and INNO-406. The Group operates in the United States of America. | Corporate Officer/Principal | - |
Opleiding van Eric Poma
The University of North Carolina at Charlotte | Doctorate Degree |
The Leonard N Stern School of Business | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
MOLECULAR TEMPLATES, INC. | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Health Technology |
Innovive Pharmaceuticals, Inc.
Innovive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology The Group's principal activity is developing compounds for the treatment of cancer. It currently have four products in development; INNO-406, tamibarotene, INNO-206 and INNO-406. The Group operates in the United States of America. | Health Technology |
Molecular Templates OpCo, Inc.
Molecular Templates OpCo, Inc. Financial ConglomeratesFinance Molecular Templates OpCo, Inc. provides medical services. The company is headquartered in Austin, TX. | Finance |